Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Aeterna Zentaris (AEZS)
NASDAQ:AEZS
Aeterna Zentaris (AEZS) Stock Price & Analysis
895 Followers
AEZS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.54 - $9.77
Previous Close$2.66
Volume761.00
Average Volume (3M)13.83K
Market Cap
$12.77M
Enterprise Value$12.72M
Total Cash (Recent Filing)C$0.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)-0.6
Beta0.90
Next Earnings
May 10, 2023EPS Estimate
-$1.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.68
Shares Outstanding4,855,876
10 Day Avg. Volume14,254
30 Day Avg. Volume13,827
Standard Deviation0.25
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.36
Price to Sales (P/S)1.71
Price to Cash Flow (P/CF)9.90
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$28.00Price Target Upside948.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aeterna Zentaris News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AEZS FAQ
What was Aeterna Zentaris’s price range in the past 12 months?
Aeterna Zentaris lowest stock price was $2.54 and its highest was $9.77 in the past 12 months.
What is Aeterna Zentaris’s market cap?
Currently, no data Available
When is Aeterna Zentaris’s upcoming earnings report date?
Aeterna Zentaris’s upcoming earnings report date is May 10, 2023 which is in 42 days.
How were Aeterna Zentaris’s earnings last quarter?
Aeterna Zentaris released its earnings results on Mar 23, 2023. The company reported -$2.56 earnings per share for the quarter, missing the consensus estimate of -$0.93 by -$1.63.
Is Aeterna Zentaris overvalued?
According to Wall Street analysts Aeterna Zentaris’s price is currently Undervalued.
Does Aeterna Zentaris pay dividends?
Aeterna Zentaris does not currently pay dividends.
What is Aeterna Zentaris’s EPS estimate?
Aeterna Zentaris’s EPS estimate is -$1.07.
How many shares outstanding does Aeterna Zentaris have?
Aeterna Zentaris has 4,855,876 shares outstanding.
What happened to Aeterna Zentaris’s price movement after its last earnings report?
Aeterna Zentaris reported an EPS of -$2.56 in its last earnings report, missing expectations of -$0.93. Following the earnings report the stock price went up 2.642%.
Which hedge fund is a major shareholder of Aeterna Zentaris?
Currently, no hedge funds are holding shares in AEZS
---
Aeterna Zentaris Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$28.00 (948.69% Upside)
$28.00 (948.69% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.44%
12-Months-Change
Fundamentals
Return on Equity
-51.21%
Trailing 12-Months
Asset Growth
-30.06%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Aeterna Zentaris
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
---
Helix BioPharma
―
Medicenna Therapeutics Corp
―
Sirona Biochem
―
Nymox Pharmaceutical
―
Telo Genomics Corp
―
---